Argus
http://www.argusresearch.com/Argus is an independent equity research firm with approximately 500 leading US companies across more than 60 industries in its coverage universe. The firm employs a simple Buy, Hold, and Sell rating system to reflect its outlook on companies.
View Older Stories View More Recent Stories
-
UPDATE: Argus Starts Harris Corp. (HRS) at Buy
-
Argus on Amazon (AMZN): Tweet Storm Won't Change Fundamentals, Sees Favorable Entry Point
-
Experience Argus Collections Management for Museum Innovators at CMA 2018
-
Mach Resources Announces First Acquisition in Partnership with Bayou City Energy
-
Argus Upgrades Cardinal Health (CAH) to Buy
-
Argus Radiology Announces Expansion of Their TeleRadiology Services into Georgia
-
Form 24F-2NT Smart Trust, Argus Divid For: Dec 31
-
Form 24F-2NT Smart Trust, Argus Divid For: Dec 31
-
OneJet Introduces Service in West Palm Beach with Inaugural Flight from Pittsburgh
-
Lucidea Offers Stellar Lineup of Client-Driven Releases Across ILS, KM and Collections Management Product Portfolio
-
NextEra Energy (NEE) PT Raised to $175 at Argus
-
HollyFrontier (HFC) PT Raised to $56 at Argus
-
Tropic Ocean Airways Expanding Service From The Miami Seaplane Base and Adding Additional New Aircraft To Its Fleet
-
Micron Technology (MU) PT Raised to $75 at Argus; Reiterates Buy
-
UPDATE: Argus Starts Laboratory Corporation of America (LH) at Buy
-
UPDATE: Argus Upgrades Unilever (UN) to Buy
-
NVIDIA (NVDA) PT Raised to $280 at Argus; Reiterates Buy
-
Second Sight Medical (EYES) Names John T. Blake as Chief Financial Officer
-
More Than 60% of Drug Safety Experts Plan To Use AI to Improve the Speed and Security of Adverse Event Case Processing
-
Second Sight Appoints John T. Blake Chief Financial Officer
-
Desert Silicon Announces Its New, Modernized Website and Corporate Look
-
OneJet Begins Nonstop Service between Kansas City and Pittsburgh
-
Argus Starts J.B. Hunt Transport Services (JBHT) at Buy Citing Strong Outlook
-
Argus Downgrades Nutrisystem (NTRI) to Hold Citing Weak Guidance
-
Second Sight Medical (EYES) Names Gregg Williams to Board
-
Second Sight Appoints Gregg Williams as Chairman of the Board of Directors
-
UPDATE: Argus Upgrades Thor Industries (THO) to Buy; Pullback Creates Entry Point
-
Energy XXI Gulf Coast Announces Fourth Quarter and Full Year 2017 Financial and Operational Results
-
Mach Resources LLC and Bayou City Energy Management LLC Announce Oil and Gas Partnership
-
Gener8 Maritime, Inc. Announces Fourth Quarter 2017 Financial Results
-
XOJET Continues Expansion with Leadership Promotions Dedicated to Commercial Transformation and Client-Centric Approach
-
Argus Reiterates Buy on United Natural Foods (UNFI) Following 2Q
-
Vornado Realty Trust (VNO) PT Lowered to $76 at Argus Citing Lower NT EPS Expectations Due to Oversupply
-
REVA Announces Recapitalization in Partnership with Directional Aviation and Financing from Goldman Sachs
-
ServiceNow (NOW) PT Raised to $201 at Argus; 'Favorably Valued by Historical Standards'
-
Argus Upgrades Noble Energy (NBL) to Buy
-
Argus Downgrades Cerner (CERN) to Hold
-
Argus opens new Africa office in Cape Town
-
Contango Announces Fourth Quarter and Year Ended 2017 Financial Results
-
Second Sight Medical Products, Inc. to Present at the B. Riley & Co. China Healthcare Investment Partnering Symposium
-
Pre-Open Movers 03/08: (ESRX) (BBRG) (EYES) Higher; (VBLT) (MYO) (MEET) Lower (more...)
-
UPDATE: Argus Upgrades Booking Holdings (BKNG) to Buy
-
UPDATE: Argus Upgrades Splunk (SPLK) to Buy
-
Second Sight Reports Fourth Quarter and Full Year 2017 Financial Results
-
UPDATE: Argus Upgrades Quest Diagnostics (DGX) to Buy
-
UPDATE: Argus Upgrades Domino's Pizza (DPZ) to Buy
-
UPDATE: Argus Starts Marvell (MRVL) at Buy
-
Second Sight Medical (EYES) Reports Expansion of Medicare Coverage for Argus II Retinal Prosthesis
-
Second Sight Announces Latest Expansion of Medicare Coverage for Argus II Retinal Prosthesis System
-
Winn-Dixie Donates More Than $51,000 to Ochsner Hospital for Children

